Image
| Date | Client | Type | Sub-Type | Amt. | Logo | Sector/Sub-Sector | Description | Tombstone Description | PSC Role | |
|---|---|---|---|---|---|---|---|---|---|---|
| Published | 08/31/2022 | The Billington Group | Mergers & Acquisitions | Buy-Side | Image
Image
|
Consumer, Food & Beverage | °µÍø³Ô¹Ï served as buy-side advisor for The Billington Group on acquisition of Carr's Billington Agriculture Ltd joint venture | The Billington Group has acquired Carr's Billington Agriculture Ltd joint venture | Financial Advisor | |
| Published | 08/31/2022 | Stronghold Energy Partners, LP | Mergers & Acquisitions | Sell-Side | $465.0 Million | Image
Image
|
Energy, Power & Infrastructure, Upstream | °µÍø³Ô¹Ï served as sell-side advisor for Stronghold Energy on its divestiture of Central Basin Platform assets in the Permian Basin to Ring Energy, Inc. | Stronghold Energy has divested Central Basin Platform assets to Ring Energy, Inc. | Financial Advisor |
| Published | 08/31/2022 | M & D Distributors | Mergers & Acquisitions | Sell-Side | Image
Image
Image
|
Services & Industrials, Distribution | °µÍø³Ô¹Ï served as sell-side advisor for Magneto & Diesel Holdings, LLC ("M&D"), a portfolio company of Warren Equity Partners, on sale to Gridiron Capital, LLC | Magneto & Diesel Holdings, LLC ("M&D"), a portfolio company of Warren Equity Partners, has been acquired by Gridiron Capital, LLC | Financial Advisor | |
| Published | 08/30/2022 | Amgen Inc. | Financing, Debt Capital Markets | Senior Notes | $3.0 Billion | Image
|
Healthcare, Biopharma | °µÍø³Ô¹Ï served as co-manager for Amgen Inc. on a senior notes offering | Senior Notes | Co-Manager |
| Published | 08/26/2022 | Cytek Biosciences, Inc. | Equity Capital Markets | At the Market Offering | $150.0 Million | Image
|
Healthcare, Life Sciences Tools & Diagnostics | °µÍø³Ô¹Ï served as placement agent for Cytek Biosciences on an ATM offering | ATM | Sole Placement Agent |
| Published | 08/26/2022 | Cytek Biosciences, Inc. | Financing, Equity Capital Markets | At the Market Offering | $150.0 Million | Image
|
Healthcare, Life Sciences Tools & Diagnostics | °µÍø³Ô¹Ï served as left bookrunner for Cytek Biosciences, Inc. on an ATM offering | At the Market Offering | Left Bookrunner |
| Published | 08/24/2022 | Fresenius Health Partners | Mergers & Acquisitions | Merger | $2.4 Billion | Image
Image
Image
|
Healthcare, Information-Driven Healthcare | °µÍø³Ô¹Ï served as buy-side advisor for Fresenius Health Partners on merger with Interwell Health and Cricket Health | Fresenius Health Partners has merged with Interwell Health and Cricket Health | Financial Advisor |
| Published | 08/16/2022 | Oak Street Health, LLC | Financing, Equity Capital Markets | CMFO | $201.8 Million | Image
|
Healthcare, Information-Driven Healthcare | °µÍø³Ô¹Ï served as bookrunner on Oak Street Health, LLC common stock follow on offering | Confidentially Marketed Follow-On Offering | Passive Bookrunner |
| Published | 08/12/2022 | Alaunos Therapeutic | Equity Capital Markets | At the Market Offering | $50.0 Million | Image
|
Healthcare, Biopharma | °µÍø³Ô¹Ï served as placement agent for Alaunos Therapeutics on an ATM offering | ATM | Sole Placement Agent |
| Published | 08/12/2022 | Alaunos Therapeutics | Equity Capital Markets | At the Market Offering | $50.0 Million | Image
|
Healthcare, Biopharma | °µÍø³Ô¹Ï served as placement agent for Alaunos Therapeutics on an ATM offering | ATM | Sole Placement Agent |
| Published | 08/11/2022 | Portillo's Restaurant Group, L.L.C. | Financing, Equity Capital Markets | Follow-On Offering | $191.6 Million | Image
|
Consumer, Restaurants | °µÍø³Ô¹Ï served as bookrunner for Portillo's Inc. on a follow-on offering | Follow-On Offering | Active Bookrunner |
| Published | 08/10/2022 | Immuneering Corporation | Equity Capital Markets | At the Market Offering | $50.0 Million | Image
|
Healthcare, Biopharma | °µÍø³Ô¹Ï served as placement agent for Immuneering Corporation on an ATM offering | ATM | Sole Placement Agent |
| Published | 08/10/2022 | LSB Industries Inc. | Financing, Equity Capital Markets | Follow-On Offering | $119.6 Million | Image
|
Chemicals | °µÍø³Ô¹Ï served as bookrunner for LSB Industries, Inc. on a follow on offering | Follow-On Offering | Passive Bookrunner |
| Published | 08/10/2022 | OrthoPediatrics Corp. | Financing, Equity Capital Markets | CMFO | $143.9 Million | Image
|
Healthcare, Med-Tech | °µÍø³Ô¹Ï served as bookrunner for Orthopediatrics Corp. on its common stock and pre-refunded warrant offering | Confidentially Marketed Follow-On Offering | Left Bookrunner |
| Published | 08/10/2022 | Cincor Pharma | Financing, Equity Capital Markets | Follow-On Offering | $258.8 Million | Image
|
Healthcare, Biopharma | °µÍø³Ô¹Ï served as bookrunner for CinCor Pharma, Inc. on a common stock and pre-funded warrant offering | Follow-On Offering | Active Bookrunner |
| Published | 08/10/2022 | Sovos Brands | Financing, Equity Capital Markets | Follow-On Offering | $136.9 Million | Image
|
Consumer, Food & Beverage | °µÍø³Ô¹Ï served as bookrunner for Sovos Brands, Inc. on a follow-on offering | Follow-On Offering | Passive Bookrunner |
| Published | 08/10/2022 | Verona Pharma plc | Financing, Equity Capital Markets | Follow-On Offering | $149.7 Million | Image
|
Healthcare, Biopharma | °µÍø³Ô¹Ï served as bookrunner for Verona Pharma on an American Depositories Share offering | Follow-On Offering | Active Bookrunner |
| Published | 08/08/2022 | Mesoblast Limited | Financing, Equity Capital Markets | PIPE | $45.1 Million | Image
|
Healthcare, Biopharma | °µÍø³Ô¹Ï served as sole placement agent for Mesoblast Limited on a PIPE offering | PIPE | Sole Placement Agent |
| Published | 08/05/2022 | EVERTEC, Inc. | Financing, Equity Capital Markets | Follow-On Offering | $200.3 Million | Image
|
Financial Services, Depositories | °µÍø³Ô¹Ï served as co-manager for EVERTEC, Inc. on a follow-on offering | Follow-On Offering | Co-Manager |
| Published | 08/03/2022 | Poseida Therapeutics, Inc. | Financing, Equity Capital Markets | CMFO | $80.5 Million | Image
|
Healthcare, Biopharma | °µÍø³Ô¹Ï served as bookrunner for Poseida Therapeutics, Inc. on a follow on offering | Confidentially Marketed Follow-On Offering | Left Bookrunner |
°µÍø³Ô¹Ï acquired TRS Advisors on 12/31/2020, Stamford Partners on 6/13/2022, DBO Partners on 10/10/2022, Aviditi Advisors on 8/23/2024 and G Squared Capital Partners on 9/12/2025, transactions completed prior were executed by the respective firm.